Kylo-26

N/A

Report date: 2025/11/03 17:03:03
NME

Base Information

Drug NameKylo-26
Drug Alias NameKylo-26
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionInhibin beta E chain modulators
TargetsInhibin beta E chain
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Hygieia Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Hygieia Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A